Randomized Double-blind Trial of Intramuscular Droperidol, Ziprasidone, and Lorazepam for Acute Undifferentiated Agitation in the Emergency Department.

Marc L Martel Brian E DriverJames R MinerMichelle H BirosJon B Cole

Published in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2020)

Droperidol was more effective than lorazepam or either dose of ziprasidone for the treatment of acute agitation in the ED and caused fewer episodes of respiratory depression.

Keyphrases

emergency department
double blind
phase iii
liver failure
placebo controlled
phase ii
clinical trial
respiratory failure
open label
study protocol
drug induced
aortic dissection
depressive symptoms
hepatitis b virus
intensive care unit
adverse drug
physical activity
respiratory tract